Device and method for suturing of internal puncture sites

Abstract
A suture applying device comprises a shaft having a nose piece attached at its distal end. The shaft and the nose piece are separated by a transition region, and a needle entry lumen in the shaft permits a flexible needle to be introduced in the distal direction. The needle is able to cross the transition region and penetrate tissue held therein and enter into a return lumen in the nose piece. The return lumen is U-shaped and acts to bend the flexible needle as it is advanced. In this way, the needle passes from the nose piece through the transition region in a proximal direction, and is able to pass through tissue within the transition region generally on the opposite side of a tissue puncture from the first suture passage. The needle then exits from the device, permitting the suture attached to the needle to be drawn fully through the device. The suture may then be tied in order to close and seal the tissue penetration.
Description




BACKGROUND OF THE INVENTION




1. Field of the Invention




The present invention relates generally to devices and methods for the percutaneous closure of body lumens. More particularly, the present invention relates to devices and methods for the percutaneous closure of arterial and venous puncture sites, which are usually accessible only through a tissue tract.




A number of diagnostic and interventional vascular procedures are now performed transluminally, where a catheter is introduced to the vascular system at a convenient access location and guided through the vascular system to a target location using established techniques. Such procedures require vascular access which is usually established using an introducer sheath according to the well known Seldinger technique, as described, for example, in William Grossman's “Cardiac Catheterization and Angiography,” 3rd Ed., Lea and Febiger, Philadelphia, 1986, incorporated herein by reference.




When vascular access is no longer required, the introducer sheath must be removed and bleeding at the puncture site stopped. One common approach for achieving hemostasis (the cessation of bleeding) is to apply external force adjacent to and upstream from the puncture site, typically by manual or “digital” compression. This approach suffers from a number of disadvantages. It is time-consuming, frequently requiring one-half hour or more of compression before hemostasis is assured. It is uncomfortable for the patient and frequently requires administering analgesics to be tolerable. Moreover, the application of excessive pressure can at times totally occlude the underlying blood vessel, resulting in ischemia and/or thrombosis. Following manual compression the patient is required to remain recumbent for at least six and at times as long as eighteen hours under close observation to assure continued hemostasis. During this time renewed bleeding may occur resulting in bleeding through the tract, hematoma, and/or pseudoaneurism formation as well as arteriovenous fistula formation. These complications may require blood transfusion and/or surgical intervention. The incidence of these complications increases when the sheath size is increased and when the patient is anticoagulated. It is clear that the standard technique for arterial closure can be risky and is expensive and onerous to the patient. While the risk of such conditions can be reduced by using highly trained individuals, such use is both expensive and inefficient.




To overcome the problems associated with manual compression, the use of bioabsorbable fasteners to stop bleeding has been proposed by several groups. Generally, these approaches rely on the placement of a thrombogenic and bioabsorbable material, such as collagen, at the superficial arterial wall over the puncture site. While potentially effective, this approach suffers from a number of problems. It can be difficult to properly locate the interface of the overlying tissue and the adventitial surface of the blood vessel, and locating the fastener too far from that surface can result in failure to provide hemostasis and subsequent hematoma and/or pseudo aneurism formation. Conversely, if the fastener intrudes into the arterial lumen, intravascular clots and/or collagen pieces with thrombus attached can form and embolize downstream causing vascular occlusion. Also, thrombus formation on the surface of a fastener protruding into the lumen can cause a stenosis which can obstruct normal blood flow. Other possible complications include infection as well as adverse reactions to the collagen implant.




For these reasons, it would be desirable to provide improved devices and methods to close and seal body lumen puncture sites. It would be particularly desirable to provide percutaneous devices and methods for suturing the puncture sites required for percutaneous vascular procedures.




2. Description of the Background Art




Devices capable of delivering needles to various tissue locations are described in the following patents and patent applications: U.S. Pat. Nos. 4,493,323 and 659,422; European patent application 140 557; and U.S.S.R patent applications 1174-036-A and 1093-329-A. Other suturing and ligating devices are described in U.S. Pat. Nos. 3,665,926; 2,959,172; and 2,646,045. Devices for sealing percutaneous vascular penetrations using various plug and fastener structures are described in U.S. Pat. Nos. 5,222,974; 5,192,302; 5,061,274; 5,021,059; 4,929,246; 4,890,612; 4,852,568; 4,744,364; 4,587,969; and 3,939,820. Collagen fastener sealing devices are under commercial development by Datascope Corp., Montvale, N.J., and Kensey Nash Corporation, Exton, Pa. U.S. Pat. No. 4,161,951, describes a needle driver to facilitate surgical suturing. U.S. Pat. No. 4,317,445, discloses a catheter having an axial lumen which provides an indication of blood flow when the catheter has been successfully introduced to the vascular system. A brochure entitled “Innovation Through Progress” published by REMA-Medizintechnik GmbH, Durbheim-Tuttlingen, Germany, describes a suturing device which carries a pair of needles with a length of suture extending therebetween at its distal end. Features of the REMA-Medizintechnik suturing device appear to be described in DE 42 10 724. A device and method for the suturing of vascular penetration sites are described in copending application Ser. No. 07/989,611, commonly assigned with the present application.




SUMMARY OF THE INVENTION




The present invention provides devices and methods for suturing tissue penetrations and puncture sites and is particularly useful for the suturing of puncture sites distal to a tissue tract, such as punctures formed in blood vessels to provide vascular access. Devices according to the present invention will comprise a needle-guiding device including a shaft having a proximal end and a distal end and will define a needle path having an entry segment, a return segment, and an exit segment. Using such devices, elongate flexible needles may be guided through tissue on either side of a puncture site by pushing on the needle from the entry segment. The needle will then pass through tissue captured in a gap or transition region between the entry segment and the return segment. The needle is resiliently flexed (elastically deformed) to turn back on itself as it passes through the return segment of the needle path and is thus directed proximally into the exit segment. The needle thus also passes through tissue captured in the gap between the return segment and the exit segment, permitting suture to be drawn by the needle through opposed sides of the puncture site. The suture may then be tied off to close the puncture in a conventional manner.




According to a first aspect of the method of the present invention, the elongate flexible needle is provided and pushed inwardly so that its distal tip penetrates through an anterior surface of the wall of a body lumen adjacent a puncture site. The flexible needle is then resiliently flexed elastically deformed) as it travels within the interior of the body lumen so that the distal tip will penetrate proximally (outwardly) through a posterior surface of the luminal wall adjacent the puncture site. As it emerges from the device, the needle straightens and may be pulled outwardly to draw suture through the needle penetrations thus formed on opposite sides of the puncture, and the suture tied off to close the puncture site.




According to a second aspect of the method of the present invention, both the elongate flexible needle and a needle-guiding device are provided. The needle-guiding device defines the needle path having an entry segment, a return segment, and an exit segment. The needle-guiding device is first introduced through a tissue tract so that a gap between the entry/exit segments and the return segment lies at the puncture site. After the needle-guiding device is in place, the flexible needle may be pushed through the entry segment of the needle path so that the needle first passes through tissue adjacent the puncture site and into the return segment of the needle path. The needle is then turned as it advances through the return segment so that it passes outwardly through tissue on the other side of the puncture site and then into the exit segment. The needle is pushed sufficiently far so that the distal end of the needle emerges from the exit segment of the needle path where it may be manually grasped and pulled from the needle-guiding device. The suture is then released from the device, the device withdrawn, and the suture tied to close the puncture site.




In a first aspect of the device of the present invention, the suturing device comprises a needle-guiding device including a shaft having a proximal end, a distal end, an entry lumen, and an exit lumen. A nose piece is attached to the distal end of the shaft and includes a return lumen disposed to receive the flexible needle from the entry lumen and to turn the needle to enter the exit lumen as the needle is advanced from the entry lumen. A gap between the shaft and the nose piece receives the tissue to be sutured and exposes the tissue to passage of the suturing needle.




Typically, the nose piece will be elongated with a tapered distal tip and will have a circular cross-section having a maximum peripheral length which is generally equal to that of a transition region which defines a tissue-receiving gap between the nose piece and the shaft. In a preferred embodiment, the nose piece will be fixed relative to the shaft. In an alternate embodiment, the nose piece will be rotatable relative to the shaft. In either case, it will be necessary for the nose piece to align the entry and exit ports of the return lumen to receive the needle from the entry lumen and direct the needle to the exit lumen.




In another aspect of the device of the present invention, guide tubes are provided together with a mechanism to selectively extend the guide tubes across the tissue-receiving gap between the entry lumen and the entry port of the return lumen and between the exit port of the return lumen and the exit lumen. The needle guide tubes help assure that the flexible needles will not become misaligned during passage through tissue across the gap between the shaft and the nose piece.




In another particular aspect of the present invention, the device further comprises a drive wheel on the shaft disposed to engage a flexible needle present in the entry lumen. In this way, even very flexible needles (lacking substantial column strength) can be advanced through the entry lumen to the return lumen and subsequently to exit lumen. The present invention still further provides a suturing kit including a needle-guiding device, as described above, in combination with a flexible needle attached to a length of suture. The needle will have a length sufficient to permit its introduction through the entry lumen, return lumen, and exit lumen, so that the needle may be advanced by pushing on the needle within the entry lumen until a distal end of the needle emerges from the exit lumen. In this way, a user can advance the needle entirely through the needle-guiding path, and grasp the needle once it is emerged from the exit lumen, either manually or using hemostats. Preferably, the needle will be from 10 cm to 30 cm in length. The needle may then be withdrawn from the needle-guiding device and the suture released from the device. After the device is withdrawn from the tissue tract, the suture may be tied off in a conventional manner.




The present invention further comprises kits including the needle guiding device, the needle, and suture. Conveniently, all three components can be packaged together in sterile packaging, such as a sterile flexible pouch.




The devices and methods of the present invention are useful wherever it is desired to place a tied suture loop to close a tissue puncture site, particularly a puncture site through the wall of a body lumen, and more particularly a percutaneous vascular puncture site at the distal end of a tissue tract. The devices and methods can achieve closure wholly within the tissue tract leading to a puncture site and can be manipulated entirely from the portion of the device lying outside of the tissue tract. The present invention will find its greatest use in the sealing of a femoral artery cannulation site made in connection with percutaneous transluminal procedures such as angiography, angioplasty, atherectomy, laser ablation, stent placement, intravascular drug delivery, intravascular imaging, and the like. The present invention will also find use in other medical procedures which rely on percutaneous access to hollow body organs and lumens, such as laparoscopic procedures, endoscopic procedures, artheroscopic procedures, and the like.











BRIEF DESCRIPTION OF THE DRAWINGS





FIG. 1

is a perspective view of a suturing device constructed in accordance with the principles of the present invention.





FIG. 1A

illustrates a flexible suturing needle attached to a length of suture, which needle and suture may be introduced using the suturing device of FIG.


1


.





FIG. 1B

illustrates an alternative distal end configuration for the suturing device of FIG.


1


.





FIG. 2

is an elevational view of the suturing device of

FIG. 1

, with portions broken away.





FIG. 3

is a detailed view of the distal end of the suturing device of

FIG. 1

, with portions broken away.





FIG. 3A

is a cross-sectional view taken along line


3


A—


3


A of FIG.


3


.





FIG. 3B

is a cross-sectional view taken along line


3


B—


3


B of FIG.


3


.





FIG. 4A

is a detailed view similar to

FIG. 3

, illustrating the release of suture from the distal end of the device.





FIG. 4B

is a cross-sectional detail of

FIG. 4A

illustrating a suture-release slot of the present invention.





FIGS. 5A-5C

illustrate the suturing device in its initial configuration prior to extension of needle guide tubes and advancement of a suturing needle.





FIGS. 6A-6C

illustrate the suturing device in an intermediate configuration after the needle guide tubes have been advanced but prior to advancement of the suturing needle within the needle guide path.





FIGS. 7A-7C

illustrate the suturing device with the needle guide tubes advanced and the suturing needle partially advanced through the needle guide path by a needle drive wheel.





FIG. 8

is a detailed view illustrating the distal end of the needle-guiding device placed within a puncture in the femoral artery prior to advancement of the needle guide tubes.





FIGS. 9-12

illustrate successive steps of advancing the suturing needle within the needle-guide path of the needle-guiding device in detail.





FIG. 13

illustrates a tied suture loop applied by the device in the method of the present invention.





FIGS. 14A-14C

illustrate an alternative arrangement of the distal end of the needle-guiding device of the present invention, where a rotatable nose piece carrying a pair of return lumens is provided for receiving a pair of needles from the guide shaft.





FIGS. 15A and 15B

illustrate placement of single and double suture loops using the first and second embodiments of the present invention.





FIGS. 16A and 16B

illustrate an alternative suture release mechanism where a portion of the nose piece slides to expose the return lumen.





FIGS. 17A and 17B

illustrates a second alternative suture release mechanism, where a portion of the nose piece swings open to expose the return lumen and release the suture.











DESCRIPTION OF SPECIFIC EMBODIMENTS




Referring now to

FIGS. 1-3

,


3


A, and


3


B, a suture applying device


10


which is suitable for suturing and sealing of a percutaneous vascular puncture site, particularly punctures made to the femoral artery in a patient's groin, will be described. It will be appreciated, however, that the device of the present invention can be readily adapted for use with punctures made to other hollow body organs and lumens, although it may be necessary to modify the dimensions and other particular aspects of the device to accommodate a different usage environment.




The suture applying device


10


of the present invention comprises an elongate shaft


12


having a nose piece


14


at its distal end and a handle


16


at its proximal end. The shaft is illustrated as an elongate cylindrical rod having a plurality of axial lumens formed therein, but could also comprise a variety of other geometries which are able to fulfill the essential requirements of the shaft, i.e., defining a needle guide path from its proximal end to its distal end and again back from the distal end to the proximal end. The shaft will usually also include or otherwise define a guide wire lumen (particularly for vascular applications), and a blood pressure detection lumen. Each of these aspects will be described in more detail with regard to the exemplary embodiment of

FIGS. 1-3

.




Shaft


12


includes a needle entry lumen


18


terminating at a needle exit port


20


at its distal end and a needle exit lumen


22


which begins with a needle entry port


24


at its distal end. The shaft


12


further includes a guide wire lumen


26


which extends through the nose piece


14


and a blood pressure detection lumen


28


having a blood inlet port


30


at its distal end. The blood inlet port


30


is located within a transition gap-defining) region


32


between the nose piece


14


and shaft


12


, as will be described in more detail hereinafter.




The nose piece


14


includes a needle return lumen


36


which is preferably a U-shaped lumen having a needle entry port


38


aligned with needle exit port


20


of the needle entry lumen


18


and a needle exit port


40


aligned with needle entry port


24


of the needle exit lumen


22


. In this way, a flexible needle


42


(

FIGS. 1A and 3

) entering through the entry lumen


18


will be able to pass across the gap defined by the transition region


32


and into the needle return lumen


36


(in some cases through a needle guide tube as described in connection with

FIG. 3

hereinafter) where its direction of travel will be reversed from the distal direction to the proximal direction. The needle


42


will then emerge from the needle exit port


40


of return lumen


36


and be able to enter the needle exit lumen


22


through aligned needle entry port


24


. Thus, tissue disposed in transition region


32


, i.e., the gap between the distal end of shaft


12


and the proximal end of nose piece


14


, will be penetrated by the flexible needle


42


on opposite sides of a puncture site, as will be described in greater detail hereinafter.




In the suturing of a puncture site in the wall of a body lumen, and in particular the wall of a blood vessel, it is desirable to minimize and preferably eliminate any tearing or enlarging of the puncture during the suturing procedure. With the device of the present invention, however, it will also be desirable to distend the periphery of the. puncture so that its edges are extended along an axis transverse to that of the blood vessel. In this way, opposed edges of the puncture will be exposed to the needle as it passes through the transition region


32


between the nose piece


14


and the shaft


12


. In order to simultaneously achieve both these objectives, i.e., distending the edges of the puncture. without tearing, and further provide a nose piece


14


having sufficient size to space the entry and exit ports of the return lumen


36


sufficiently far apart to be aligned with needle ports


20


and


24


, the geometry of the nose piece


14


and of the transition region


32


are selected to properly configure and conform the edges of the luminal puncture as the suture applying device


10


is introduced therethrough.




In particular, the nose piece


14


will be tapered from a small-diameter. generally circular distal tip


50


to a proximal portion or length


52


having a generally oval configuration, as best illustrated in

FIGS. 3 and 3A

. In the illustrated embodiment, the nose piece


14


is generally conical until a circular junction


53


is reached. The proximal portion


52


of the tip makes a transition from a circular cross-section at


53


to an oval cross-section at


55


. The particular dimensions of the tip will be selected based on the intended use of the device


10


. For the suturing and sealing of the femoral artery, the distal tip


50


will typically have a diameter from about 0.25 mm to 1 mm, typically being just large enough to receive the guide wire GW into the guide wire lumen


26


. The maximum dimensions of the oval-shaped proximal portion at


55


will be in the range from 2 mm to 4.5 mm (major diameter) and in the range from 1 mm to 2.25 mm (minor diameter). In particular the major diameter will be selected to permit the needle entry port


38


to be sufficiently spaced-apart from the needle exit port


40


to provide a desired distance between the entry and exit penetrations of the suturing needle through the tissue surrounding the luminal puncture. The oval cross-section of the proximal end


55


of the proximal portion


52


is thus desirable since it minimizes the total peripheral length about the nose piece which must pass through the luminal wall puncture while maximizing the distance between the entry port


38


and exit port


40


, as just described. In this way, proper spacing of the needle passages through the tissue will be provided with minimum stretching or enlargement of the luminal penetration.




The geometry of the transition region


32


will also be chosen to provide for proper manipulation and positioning of the tissue surrounding the luminal puncture site with minimum distending (and preferably no tearing) of the edges of the puncture site. In the embodiment of

FIGS. 1-3

, the transition region


32


will conform at its distal end to the oval shape of the proximal end


55


of the proximal portion


52


of nose piece


14


. The cross-sectional orientation of the transition region


32


changes in the proximal direction, eventually becoming an oval


57


having its major axis disposed orthogonally (i.e. at 90°) relative to the major axis of the proximal portion


52


of nose piece


14


(FIG.


3


B). The oval cross-section of the transition region


32


will rotate 90° from the position at


55


to the position at


57


. That is, the peripheral shape and distance will remain constant, but the orientation of the major axis will turn through 90° over the axial length of the transition region. By maintaining a constant total peripheral length around the transition region at all points (e.g., equal to the outer diameter of the introducer sheath which had been used in performing the intravascular procedure and removed prior to suturing), the luminal penetration is held firmly and turned to the desired orientation without further distending or tearing.




An alternative nose piece


15


configuration for the suturing device


10


is illustrated in FIG.


1


B. The nose piece


15


comprises a tapered distal tip


51


, a generally cylindrical shank portion


53


, and a proximal portion


55


A (which is similar to the proximal portion


52


of the previous embodiment). A needle return lumen


59


is formed in the proximal portion


55


A and is generally identical to the lumen


42


described above. The nose piece


15


will be longer than the nose piece


14


, typically having a length in the range from 15 cm to 30 cm, usually about 20 cm. The purpose of the longer nose piece


15


is to allow the suturing device


10


to be partially withdrawn from the luminal puncture. By partially withdrawing the device


10


, the suture can be released from the nose piece, and the suture partly tightened prior to total withdrawal of the device. In this way, the puncture can be at least partly closed by the suture prior to removal of the device, and hemostasis can be maintained to limit blood loss prior to complete closure of the puncture.




Usually, both the tapered distal tip


51


and the shank


53


will have circular cross-sections, with the peripheral length of the shank being uniform along its length and generally equal to the maximum peripheral length of the nose piece, usually having a diameter equal to that of the introducer sheath which had previously been in place in the puncture. The proximal end portion


55


serves as a transition from the circular peripheral shape of the shank


53


to an oval transition region


59


, which will generally be identical to the transition region


32


in device


10


.




The remaining description herein will refer specifically to devices


10


having the nose piece


14


illustrated in

FIGS. 1

,


2


,


3


, et seq, but it will be appreciated that such description applies as well to devices incorporating nose piece.


15


.




The suturing needle


42


and attached suture:


62


are illustrated in detail in FIG.


1


A. Suturing needle


42


will be formed from a highly flexible material which will be able to pass through the radius of return lumen


36


. Typically, the turn radius will be in the range from about 1 mm to 2.25 mm, and the needle


42


will have to be able to pass through this radius without undergoing substantial permanent (non-elastic) deformation which would cause binding or jamming as the needle passes outward from the return lumen


42


. Preferably, the needle


42


will be formed from stainless spring steel or a superelastic material, typically nickel titanium alloy. Preferred superelastic nickel titanium alloys are available commercially from suppliers, such as Shape Memory Applications, Sunnyvale; Calif., Innovative Technologies International, Beltsville, Md. and Fort Wayne Metals, Fort Wayne, Ind. The diameter of the needle will typically be from about 0.2 to 0.5 mm, and the length will be sufficient to permit the needle to be advanced through the entry lumen


18


, across the return lumen


36


, and outward through the exit lumen


20


, while the needle is being pushed from a location at or near the proximal end of the entry lumen. Typically, the needle will have a length in the range from about 10 cm to 30 cm, preferably in the range from about 15 cm to 20 cm. The needle will be attached to a length of suture, typically from about 50 cm to 100 cm, usually at the proximal end of the needle. Particular methods for forming needles and attaching needles to suture are well known in the art.




Referring now to

FIGS. 4A and 4B

, in a preferred embodiment of the present invention, suture


62


(

FIG. 1A

) will be released from the nose piece


14


through a suture-release slot


60


. The needle return lumen


36


in nose piece


14


will have a diameter which is large enough to receive the flexible needle


42


with a clearance in the range from 0.03 mm to 0.1 mm. The width of the suture-release slot


60


, however, will be less than the diameter of the flexible needle


42


, typically from 0.1 mm to 0.35 mm. In this way, the needle will travel through the return lumen


36


and will not be able to escape through the suture-release slot


60


. Suture


62


which is attached to the butt end of the flexible needle


42


will be sufficiently small to pass through the suture-release slot


60


. Thus, after the needle


42


has passed entirely through the needle return lumen


36


and into the needle exit lumen


22


in shaft


12


, the suture


62


will pass out of the nose piece


14


through the suture release slot


60


, as illustrated in steps (1), (2), and (3) in FIG.


4


A. The suture


62


will thus directly engage the posterior side of the tissue to be sutured, leaving the nose piece


14


free to be withdrawn through the luminal puncture without entanglement with the suture


62


.

FIG. 4B

illustrates a proximal or trailing end


64


of the flexible needle


62


as it passes through the needle return lumen


36


. As can be seen, the suture


62


passes into the suture-release slot


60


as it is drawn through the return lumen


36


by the needle


42


. Alternative suture-release mechanisms will be described in connection with

FIGS. 16A

,


16


B,


17


A, and


17


B, hereinafter.




In a preferred aspect of the present invention, the nose piece


14


will include a soft tip


66


to facilitate entry into the body lumen being sutured. Conveniently, the soft tip


66


can be formed from a soft polymer, such as a polyether block amide, e.g., Pebax®. The soft tip


66


can be joined to the more rigid proximal portion of the nose piece


14


by any conventional manner. In all other ways, the soft tip can form a continuous structure with the proximal portion of the nose piece


14


. The proximal portion of nose piece


14


, the transition region


32


, and the shaft


12


, will typically be formed from a relatively rigid polymer (e.g., polycarbonate) or a metal (e.g., stainless steel) by conventional methodologies, such as extrusion, molding, machining and the like. The different portions of the device may be formed in separate pieces, and joined later, e.g. by the use of adhesives, heat bonding, mechanical attachment or the like.




Referring now to

FIGS. 1

,


2


, and


5


A-


5


C, a needle guide and advancement mechanism constructed in accordance with the principles of the present invention will be described. The needle guide and advancement mechanism includes an entry guide tube


70


and an exit guide tube


72


, each being secured at its proximal end in a guide tube yoke


74


. The guide tubes


70


and


72


are slidably received in the needle entry lumen


18


and needle exit lumen


22


, respectively, so that axial translation of the guide tube yoke


74


(as described hereinafter) can advance the distal ends of the guide tubes across the gap defined by the transition region


32


(as illustrated in FIG.


3


and described in more detail in connection with FIGS.


6


A-


6


C). The guide tube yoke


74


, in turn, is slidably mounted in a spring retainer


76


, with a spring


78


being disposed therebetween. As illustrated in

FIGS. 5A and 5B

, spring


78


is in compression, with the entire assembly of the guide tubes


70


and


72


and guide tube yoke


74


being in a retracted configuration, i.e. fully to the left in

FIGS. 5A and 5B

.




A yoke-release mechanism comprises a thumb lever


80


extending from handle


16


and a latch member


82


which captures the guide tube yoke


74


through an extension


84


. The thumb lever


80


and latch member


82


are pivotally mounted within the handle and are operatively connected through a pin and slot


86


so that depression of thumb lever


80


in the direction of arrow


88


will release the guide tube yoke extension


84


, as illustrated in

FIGS. 6A-6C

. In this way, spring


80


will, decompress to translate the guide tube yoke


74


distally, i.e. toward the right, as illustrated in

FIGS. 6A-6C

.




The entry guide tube


70


will carry the flexible suture needle


42


with a sharpened distal tip


90


projecting just out of the distal end of the tube, as illustrated in

FIGS. 5A and 5C

. In this way, the needle


42


will fill the lumen of the guide tube


70


and prevent tissue from entering the lumen as the guide tube is advanced. The exit guide tube


72


will have a stylet


92


(or other obturator) filling its axial lumen. As illustrated in

FIGS. 5A and 5C

, the stylet


92


will preferably also have a sharpened distal tip


94


which projects outwardly from the distal end of the guide tube as the guide tube is advanced. The purpose of the stylet


92


is to prevent tissue from entering (and blocking) lumen of guide tube


72


as it is advanced through the tissue. After the exit guide tube


72


has been advanced across the transition region


32


, the stylet


92


will be withdrawn leaving the lumen of the guide tube open and available for advancement and passage of the flexible needle


42


, as will be described in greater detail in connection with

FIGS. 7A-7C

.




Referring now in particular to

FIGS. 1

,


2


, and


5


A-


5


C, the exemplary needle guide and advancement mechanism for use with the device of the present invention further comprises a drive wheel


100


rotatably mounted in yoke


102


. The yoke


102


, in turn, is attached to the interior of handle


16


on a spring mount


104


. Spring mount


104


urges the drive wheel


100


against flexible suture needle


42


in a manner described more fully in connection with

FIGS. 6A-6C

. Preferably, the periphery


106


of the drive wheel


100


is serrated or otherwise roughened to enhance frictional coupling between the drive wheel and the needle


42


to facilitate advancement.




Drive wheel


100


is driven by a rack


110


which engages pinion gear


112


which is coaxially mounted and attached to the drive wheel. The rack


110


, in turn, is actuated by a lever


114


which is pivotally attached to the handle


16


. A mechanism (not illustrated) will usually be provided for biasing the rack


110


against the pinion gear


112


. For example, a leaf spring could be provided within the yoke to upwardly bias the rack


110


against the pinion gear


110


. Alternatively, a torsion spring could be provided at the pivot


116


connecting the rack


110


to the lever


114


.




The drive wheel


100


is actuated by manually squeezing the lever


114


toward the handle


16


in the direction of arrow


118


. It will be possible to select the relative diameters of the drive wheel


100


and the pinion gear


112


and the length and pivot point of the rack so that a single stroke of the lever


114


can fully drive the needle through the target tissue, return lumen


36


, and needle exit lumen


22


, so that the needle can be manually grasped or mechanically captured, e.g., using hemostats, as it emerges from the exit lumen. Alternatively, a mechanism (not illustrated) could be provided to permit multiple, sequential actuation of the lever


114


in order to drive the needle the requisite distance.




The suture applier


10


is illustrated in its “shelf” configuration in FIGS.


2


and


5


A-


5


C. That is, the needle guide tubes


70


and


72


are fully retracted, i.e. drawn to the left in each of these figures. By depressing thumb lever


80


, the user releases the guide tube yoke


74


, thus driving the guide tubes in the distal direction as indicated by arrows


120


in FIG.


6


A. Such movement of the entry guide tube


70


aligns an elongate cutout


122


in the guide tube with the periphery of drive wheel


100


, as best illustrated in FIG.


6


B. In this way, the drive wheel


100


directly engages the side of the suture needle


42


which is exposed through the cutout


122


. At this moment, the guide tubes will also extend across the transition region


32


and seat into the return lumen


36


in the nose piece


14


. The stylet


92


may then be withdrawn in order to open the lumen of the exit guide tube


72


so that it is free to receive the suture needle.




After the stylet


92


is withdrawn, the needle


42


may be advanced by the needle advance mechanism, as illustrated in

FIGS. 7A-7C

. The lever


114


is manually closed in the direction of arrow


130


to translate rack


110


across the pinion gear


112


. This motion causes drive wheel


100


to rotate clockwise in the direction of arrow


132


. As the drive wheel


100


is engaging suture needle


42


through the cutout


122


, the needle will be moved in the distal direction (arrow


134


) causing the sharpened tip


90


to advance and cross the gap defined by transition region (arrow


136


), through the return lumen


36


and back through the transition region gap (arrow


138


). The needle advancement mechanism will be actuated sufficiently (or for a sufficient number of times) to advance the needle


42


so that its distal end


90


emerges from the proximal end of the device


10


, as illustrated in broken line in FIG.


7


A. The needle may then be grasped or captured and withdrawn from the device


10


in order to draw the suture through the device and the tissue to be sutured, as will be described in more detail hereinafter.




It would also be possible to modify the drive wheel


100


advance mechanism to engage and advance the guide tube


70


so that the guide tube could be advanced by an initial portion of the stroke of lever


114


. Guide tube


70


could be coupled to guide tube


72


through a yoke similar to the yoke


74


, but no spring


78


or yoke-release mechanism would be required. A variety of particular mechanisms for advancing the guide tubes and/or needles would be available within the scope of the present invention.




Referring now to

FIGS. 8-13

, use of the device


10


for applying end tying a suture loop in a blood vessel BV wall will be described in detail. Referring in particular to

FIG. 8

, the device


10


is introduced through an existing tissue tract T, typically formed by an introducer sheath which has been previously placed in connection with a conventional intravascular therapeutic or diagnostic procedure, such as angiography, angioplasty, atherectomy, laser ablation, cardiac mapping, cardiac ablation, or the like. The introducer sheath is removed prior to introduction of the nose piece


14


of the suturing device


10


. As discussed above, the maximum peripheral length of the nose piece


14


will generally be the same as the circumferential length of the introducer sheath so that the penetration is not torn but remains blocked or occluded by the device to reduce blood loss.




The device


10


is introduced with the needle guide tubes


70


and


72


fully retracted in the proximal direction and with the stylet


92


in place in the lumen of the exit guide tube


72


. The device


10


is positioned over the previously placed guide wire GW and introduced sufficiently so that the gap, defined by the transition region


32


receives the edges of the puncture P. Conveniently, proper positioning of the device


10


can be confirmed by detecting the flow of blood into blood inlet port


30


And as it appears at the open proximal end of lumen


28


.




After the device


10


has been properly positioned, as illustrated in

FIG. 8

, the needle guide tubes


70


and


72


will be advanced across the gap defined by the transition region


32


, as illustrated in FIG.


9


. The needle advancement mechanism, as previously described, will be used to effect the advance. Each guide tube


70


and


72


will pass through tissue which is located within the transition region


32


. The presence of the flexible needle


42


in guide tube


70


prevents “coring” of the tissue into the guide tube


70


. Similarly, the presence of stylet


92


in needle guide tube


72


prevents such coring.




The stylet


92


is next withdrawn, leaving the lumen of the needle guide tube


72


empty and available to receive flexible needle


42


, as illustrated in FIG.


10


.




The flexible needle


42


is next advanced across the U-shaped return lumen


36


and into the needle return guide


72


, as illustrated in FIG.


11


. Note that the highly flexible nature of the needle together with the close fit between the needle, guide tubes


70


and


72


, and return lumen


32


, permits it to turn across the small radius and advance with buckling in spite of the frictional and bending forces opposing the needle's advance. The needle continues to be advanced until the sharpened distal tip


90


emerges from the device


10


(as illustrated previously in FIG.


7


A). After it emerges, the needle tip


90


may be grasped and pulled through the device


10


, drawing the suture


62


through the return lumen


36


. The needle guide tubes


70


and


72


will be withdrawn, permitting the suture to be drawn outward from the nose piece through the suture-release slot


60


, as illustrated in

FIGS. 4A-4B

and


12


(where the outer portion of slot


60


is shown broken away). After the suture has been released from the nose piece


14


, the device


10


may be partially or totally withdrawn, leaving the suture accessible for tying of a knot K to close the puncture wound, as illustrated in FIG.


13


.




When using a device


10


having an elongated nose piece


15


, as illustrated in

FIG. 1B

, it will be preferred to only partially withdraw the device so that the shank portion


53


remains within the penetration P. As the shank


53


will preferably have a perimeter substantially equal to that of the introducer sheath previously in place, the shank will be able to occlude the puncture to inhibit blood loss, without distending the puncture. The extra length provided by shank


53


permits the nose piece


15


to be withdrawn sufficiently to release the suture


62


while still occluding the penetration P. The knot K can thus be tied and partially tightened prior to total withdrawal of the device


10


, allowing very rapid closure of the penetration by tightening the suture.




Referring now to

FIGS. 14A-14C

an alternative embodiment of a nose piece


200


is illustrated. Nose piece


200


is mounted on an axial rod


202


which permits it to be rotated between an aligned position, as illustrated in

FIG. 14B

, and a transverse position, as illustrated in

FIGS. 14A and 14C

. When in the aligned position of

FIG. 14B

, the nose piece has an oval cross-section which gradually increases in size and which forms a smooth and continuous surface with the transition region


204


, facilitating introduction of the device through a tissue puncture. The peripheral length of the oval section is matched with the circumference of the introducer sheath used in the initial interventional or diagnostic procedure to minimize distending of the tissue around the luminal puncture site. In the configuration of

FIG. 14B

, the return lumens


208


and


210


, however, are out of rotational alignment with the needle entry lumens


212


and


214


and needle exit lumens


216


and


218


. Therefore, prior to needle advancement, the needle entry and exit lumens will be properly aligned with the needle return lumens in the nose piece


200


by rotating the nose piece


200


by 90° to the position of

FIGS. 14A and 14C

. The nose piece


200


will then be rotated back to the aligned configuration of

FIG. 14B

after suture release from the nose piece


200


and prior to withdrawal of the device from the tissue tract.




As can be seen in

FIGS. 15A and 15B

, the embodiment of

FIGS. 1-7

can be used to form a single suture loop where the nose piece


14


has a relatively small peripheral length (as illustrated on the right-hand half of each figure). The embodiment of

FIGS. 14A-14C

is particularly useful for forming pairs of suture loops, as illustrated on the left-hand side of Peach of

FIGS. 15A and 15B

. Of course, the embodiment of

FIGS. 1-7

could be readily adapted to place two sutures simultaneously, while the nose cone of

FIGS. 14A-14C

could be modified to place only a single suture.




Referring now to

FIGS. 16A and 16B

, a first alternative suture release mechanism is illustrated. A nose piece


300


includes a sliding cover


302


which may be moved from the covered configuration (

FIG. 16A

) to the uncovered configuration (

FIG. 16B

) by sliding the cover proximally, as illustrated by arrow


304


. When the cover is moved proximally, return lumen


308


is exposed, permitting the suture


62


to exit from the lumen, as illustrated by arrows


310


.




A second suture release mechanism is illustrated in

FIGS. 17A and 17B

. The mechanism is similar to that illustrated in connection with

FIGS. 16A and 16B

, except that cover


400


on nose piece


402


is pivotally attached to open as illustrated in FIG.


17


B. Suture


62


can thus be released from the return lumen


404


, as illustrated by the arrows


406


.




Although the foregoing invention has been described in detail for purposes of clarity of understanding, it will be obvious that certain modifications may be practiced within the scope of the appended claims.



Claims
  • 1. A method of closing a puncture in a blood vessel wall, the method comprising:positioning a suture placement device in a tissue tract and into a puncture in the blood vessel wall; advancing a length of suture in a distal direction from the device through a first penetration in the blood vessel wall adjacent to the puncture; guiding the suture length from the first penetration across a proximal side of the puncture to a second penetration adjacent to the puncture opposite the first penetration; advancing the suture length in a proximal direction through the second penetration and the device so that the two ends of the suture length are accessible external to the tissue tract; and securing the suture length across an anterior side of the puncture to close the puncture.
  • 2. The method of claim 1, wherein advancing a length of suture in a distal direction comprises pushing a needle which carries the suture through the first penetration.
  • 3. The method of claim 2, wherein guiding the suture length comprises elastically bending the needle as it tracks within the blood vessel to the second penetration.
  • 4. The method of claim 3, wherein advancing the suture in a proximal direction comprises pushing the needle so that a needle tip passes proximally out through the tissue tract.
  • 5. A method for suturing a puncture site in a wall of a blood vessel, said method comprising:providing a suturing device having a pair of axially advanceable penetrating elements; advancing the penetrating elements to form two penetrations in the blood vessel wall on opposite sides of the puncture site; advancing suture distally through the suture device distally through one of the two penetrations into a lumen of the blood vessel, proximally through the other of the two penetrations, and proximally through the suturing device; and securing the suture to close the puncture site.
  • 6. The method of claim 5, wherein the penetrating elements are needle guides.
  • 7. The method of claim 6, wherein advancing the suture comprises pushing the suture distally through a lumen of a first needle guide tube and pulling the suture proximally through a second needle guide tube.
  • 8. The method of claim 7, wherein advancing the suture comprises providing a needle having the suture attached thereto and pushing the needle distally through the lumen of the first needle guide tube and pulling the needle proximally through the second needle guide tube.
  • 9. A method of suturing a puncture site in a wall of a blood vessel, said method comprising:providing a length of suture; pushing the suture distally through a tissue tract over the puncture site through a penetration on one side of the puncture site into a lumen of the blood vessel; pulling the suture proximally through a second penetration on another side of the puncture site and proximally through the tissue tract; and securing the suture to close the puncture site.
  • 10. A device for suturing a puncture in a blood vessel wall, said device comprising:a body arranged to be positioned through a tissue tract over the blood vessel puncture, said body having a path for, (a) advancing a suture length in a distal direction past a first gap in the body, (b) advancing the suture laterally on a distal side of the gap, and (c) proximally through a second gap in the body, wherein the gaps are arranged to capture the edges of the blood vessel wall adjacent to the puncture so that the suture advances distally through one edge, laterally across a distal side of the puncture, and proximally through the other edge of the puncture.
  • 11. The device according to claim 10, wherein the body comprises a shaft having a nose piece, wherein the gaps are positioned between a distal end of the shaft and a proximal surface of the nose piece.
  • 12. The device according to claim 10, wherein the device further includes a needle, the needle being configured to carry the suture through the suture path.
  • 13. The device according to claim 12, wherein the device further comprises a pair of needle guide tubes, said guide tubes arranged to be advanced across the gaps to penetrate the edges of the blood vessel wall to form penetrations prior to advancement of the needle.
Parent Case Info

This application is a continuation of and claims benefit of U.S. application Ser. No. 08/638,076, filed Apr. 26, 1996; now U.S. Pat. No. 5,792,152 which is a continuation of U.S. application Ser. No. 08/148,809, filed Nov. 8, 1993; now U.S. Pat. No. 5,527,322 which is a continuation of U.S. application Ser. No. 09/057,108, filed Apr. 8, 1998 now U.S. Pat. No. 6,206,893 the disclosures of which are incorporated by reference.

US Referenced Citations (185)
Number Name Date Kind
312408 Wackerhagen Feb 1885 A
659422 Shidler Oct 1900 A
2127903 Bowen Aug 1938 A
2397823 Walter Apr 1946 A
2646045 Priestley Jul 1953 A
2959172 Held Nov 1960 A
3104666 Hale et al. Sep 1963 A
3470875 Johnson Oct 1969 A
3653388 Tenckhoff Apr 1972 A
3665926 Flores May 1972 A
3776237 Hill et al. Dec 1973 A
3820544 Semm Jun 1974 A
3926194 Greenberg et al. Dec 1975 A
3939820 Grayzel Feb 1976 A
4018228 Goosen Apr 1977 A
4109658 Hughes Aug 1978 A
4161951 Scanlan, Jr. Jul 1979 A
4168073 LaRue Sep 1979 A
4182339 Hardy, Jr. Jan 1980 A
4216776 Downie et al. Aug 1980 A
4235177 Arbuckle Nov 1980 A
4317445 Robiinson Mar 1982 A
4411654 Boarini et al. Oct 1983 A
4412832 Kling et al. Nov 1983 A
4437465 Nomoto et al. Mar 1984 A
4493323 Albright et al. Jan 1985 A
4553543 Amarsinghe Nov 1985 A
4587969 Gillis May 1986 A
4596559 Fleishhacker Jun 1986 A
4629450 Suzuki et al. Dec 1986 A
4651733 Mobin-Uddin Mar 1987 A
4723549 Wholey et al. Feb 1988 A
4738666 Fuqua Apr 1988 A
4744364 Kensey May 1988 A
4803984 Narayanan et al. Feb 1989 A
4836205 Barrett Jun 1989 A
4852568 Kensey Aug 1989 A
4890612 Kensey Jan 1990 A
4898155 Ovil et al. Feb 1990 A
4911164 Roth Mar 1990 A
4926860 Stice et al. May 1990 A
4929246 Sinofsky May 1990 A
4935027 Yoon Jun 1990 A
4957498 Caspari et al. Sep 1990 A
4983168 Moorehead Jan 1991 A
4984581 Stice Jan 1991 A
5002563 Pyka et al. Mar 1991 A
5009643 Reich et al. Apr 1991 A
5021059 Kensey et al. Jun 1991 A
5037433 Wilk et al. Aug 1991 A
5047039 Avant et al. Sep 1991 A
5059201 Asnis Oct 1991 A
5061274 Kensey Oct 1991 A
5078721 McKeating Jan 1992 A
5080664 Jain Jan 1992 A
5100419 Ehlers Mar 1992 A
5100432 Matsutani Mar 1992 A
5109780 Slouf et al. May 1992 A
5129913 Ruppert Jul 1992 A
5147373 Ferzli Sep 1992 A
5160339 Chen et al. Nov 1992 A
5171251 Bregen et al. Dec 1992 A
5192294 Blake, III Mar 1993 A
5192302 Kensey et al. Mar 1993 A
5219358 Bendel et al. Jun 1993 A
5222974 Kensey et al. Jun 1993 A
5234443 Phan et al. Aug 1993 A
5242427 Bilweis Sep 1993 A
5250033 Evans et al. Oct 1993 A
5250053 Snyder Oct 1993 A
5254126 Filipi et al. Oct 1993 A
5258003 Ciaglia et al. Nov 1993 A
5279311 Snyder Jan 1994 A
5285945 Brinkerhoff et al. Feb 1994 A
5289963 McGarry et al. Mar 1994 A
5290284 Adair Mar 1994 A
5290297 Phillips Mar 1994 A
5292309 Van Tassel et al. Mar 1994 A
5292332 Lee Mar 1994 A
5293881 Green et al. Mar 1994 A
5295993 Green Mar 1994 A
5300085 Yock Apr 1994 A
5304184 Hathaway et al. Apr 1994 A
5304185 Taylor Apr 1994 A
5306254 Nash et al. Apr 1994 A
5312024 Grant et al. May 1994 A
5320632 Heidmueller Jun 1994 A
5336229 Noda Aug 1994 A
5336230 Leichtling et al. Aug 1994 A
5336231 Adair Aug 1994 A
5342369 Harryman, II Aug 1994 A
5354312 Brinkerhoff et al. Oct 1994 A
5364408 Gordon Nov 1994 A
5368601 Sauer et al. Nov 1994 A
5374275 Bradley et al. Dec 1994 A
5376096 Foster Dec 1994 A
5383896 Gershony et al. Jan 1995 A
5387221 Bisgaard Feb 1995 A
5387227 Grice Feb 1995 A
5395332 Ressemann et al. Mar 1995 A
5395349 Quiachon et al. Mar 1995 A
5397325 Delia Badia et al. Mar 1995 A
5403329 Hinchcliffe Apr 1995 A
5403338 Milo Apr 1995 A
5411481 Allen et al. May 1995 A
5413571 Katsaros et al. May 1995 A
5417699 Klein et al. May 1995 A
5425705 Evard et al. Jun 1995 A
5431666 Sauer et al. Jul 1995 A
5433700 Peters Jul 1995 A
5452733 Sterman et al. Sep 1995 A
5454822 Schöb et al. Oct 1995 A
5454834 Boebel et al. Oct 1995 A
5458574 Machold et al. Oct 1995 A
5470338 Whitefield et al. Nov 1995 A
5476469 Hathaway et al. Dec 1995 A
5476470 Fitzgibbons, Jr. Dec 1995 A
5478309 Sweezer et al. Dec 1995 A
5478353 Yoon Dec 1995 A
5480407 Wan et al. Jan 1996 A
5486190 Green Jan 1996 A
5489295 Piplani et al. Feb 1996 A
5496332 Sierra et al. Mar 1996 A
5507744 Tay et al. Apr 1996 A
5507755 Gresl et al. Apr 1996 A
5507757 Sauer et al. Apr 1996 A
5507758 Thomason et al. Apr 1996 A
5509902 Raulerson Apr 1996 A
5520665 Fleetwood May 1996 A
5520702 Sauer et al. May 1996 A
5527321 Hinchliffe Jun 1996 A
5527322 Klein et al. Jun 1996 A
D372310 Harnett Jul 1996 S
5531700 Moore et al. Jul 1996 A
5540701 Sharkey et al. Jul 1996 A
5540704 Gordon et al. Jul 1996 A
5545171 Sharkey et al. Aug 1996 A
5545178 Kensey et al. Aug 1996 A
5545180 Le et al. Aug 1996 A
5549618 Fleenor et al. Aug 1996 A
5554162 DeLange Sep 1996 A
5562686 Sauer et al. Oct 1996 A
5562688 Riza Oct 1996 A
5562728 Larzarus et al. Oct 1996 A
5569271 Hoel Oct 1996 A
5573540 Yoon Nov 1996 A
5591179 Edelstein Jan 1997 A
5591206 Moufarrège Jan 1997 A
5593421 Bauer Jan 1997 A
5603718 Xu Feb 1997 A
5611794 Sauer et al. Mar 1997 A
5613974 Andreas et al. Mar 1997 A
5613975 Christy Mar 1997 A
5643289 Sauer et al. Jul 1997 A
5669917 Sauer et al. Sep 1997 A
5700273 Buelna et al. Dec 1997 A
5713910 Gordon et al. Feb 1998 A
5716369 Riza Feb 1998 A
5720757 Hathaway et al. Feb 1998 A
5728151 Garrison et al. Mar 1998 A
5741276 Poloyko et al. Apr 1998 A
5741280 Fleenor Apr 1998 A
5759188 Yoon Jun 1998 A
5766183 Sauer Jun 1998 A
5766186 Faraz et al. Jun 1998 A
5779719 Klein et al. Jul 1998 A
5792151 Heck et al. Aug 1998 A
5799661 Boyd et al. Sep 1998 A
5810850 Hathaway et al. Sep 1998 A
5817113 Gifford, III et al. Oct 1998 A
5820631 Nobles Oct 1998 A
5824010 McDonald Oct 1998 A
5830125 Scribner et al. Nov 1998 A
5836955 Buelna et al. Nov 1998 A
5836956 Buelna et al. Nov 1998 A
5846253 Buelna et al. Dec 1998 A
5860990 Nobles et al. Jan 1999 A
5860991 Klein et al. Jan 1999 A
5902311 Andreas et al. May 1999 A
5904697 Gifford, III et al. May 1999 A
5951590 Goldfarb Sep 1999 A
5954732 Hart et al. Sep 1999 A
6036699 Andreas et al. Mar 2000 A
6048351 Gordon et al. Apr 2000 A
6117144 Nobles et al. Sep 2000 A
Foreign Referenced Citations (35)
Number Date Country
4210724 Jul 1993 DE
9217932 Jul 1993 DE
140557 May 1985 EP
207545 Jan 1987 EP
0474887 Mar 1992 EP
478358 Apr 1992 EP
542126 May 1993 EP
568098 Nov 1993 EP
589409 Mar 1994 EP
624343 Nov 1994 EP
669103 Aug 1995 EP
568098 Oct 1997 EP
669102 Oct 1998 EP
669101 Sep 1999 EP
1059544 Jul 1952 FR
2119866 May 1990 JP
542161 Feb 1993 JP
993922 Feb 1983 SU
1093329 May 1984 SU
1174036 Aug 1985 SU
1544383 Feb 1990 SU
1648400 May 1991 SU
820810 Jun 1997 SU
WO 9405213 Mar 1994 WO
WO 9427503 Dec 1994 WO
WO 9428801 Dec 1994 WO
WO 9505121 Feb 1995 WO
WO 9535065 Feb 1995 WO
WO 9535065 Dec 1995 WO
WO 9703613 Feb 1997 WO
WO 9710764 Mar 1997 WO
WO 9713461 Apr 1997 WO
WO 9717901 May 1997 WO
WO 9720505 Jun 1997 WO
WO 0012013 Mar 2000 WO
Non-Patent Literature Citations (6)
Entry
Elgin National Watch Company, Product Brochure entitled “Elgiloy®, A Cobalt Nickel Spring Alloy,” 33 pages.
Faulkner, Catherine B., Letter regarding “VasoSeal Vascular Hemostasis,” Datascope, New Jersey, 1 page only.
Laurus Medical Corporation, “Endoscopic Suturing Made Simple,” The Laurus ND-2600 Needle Driver, Irvine, CA., 1 page.
Product Brochure, Laurus Medical Corporation, Irvine, CA “The Laurus In-Line Endoscopic Suturing Device” (Oct. 1994) 1 page.
Rema-Medizintcchnik GmbH, Product Brochure entitled “REMA,” 7 pages.
Sutura™, “A New Choice In Vascular Suturing . . . ,” Let Sutura Show You—TCT Booth 846, Fountain Valley, CA.; www. suturainc.com., 1 page only.
Continuations (3)
Number Date Country
Parent 09/057108 Apr 1998 US
Child 09/769109 US
Parent 08/638076 Apr 1996 US
Child 09/057108 US
Parent 08/148809 Nov 1993 US
Child 08/638076 US